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The plasma membrane represents a critical interface between the internal and
extracellular environments, and harbors multiple proteins key receptors and transporters
that play important roles in restriction of intracellular infection. We applied plasma
membrane profiling, a technique that combines quantitative mass spectrometry with
selective cell surface aminooxy-biotinylation, to Bacille Calmette–Guérin (BCG)-infected
THP-1 macrophages. We quantified 559 PM proteins in BCG-infected THP-1 cells.
One significantly upregulated cell-surface protein was the cholesterol transporter
ABCA1. We showed that ABCA1 was upregulated on the macrophage cell-surface
following infection with pathogenic mycobacteria and knockdown of ABCA1 resulted
in increased mycobacterial survival within macrophages, suggesting that it may be a
novel mycobacterial host-restriction factor.
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INTRODUCTION
Mycobacterium tuberculosis (Mtb) is a human intracellular pathogen that causes tuberculosis
(TB) – a major global disease with 9.0 million new cases and 1.5 million deaths a year. Human
beings have been the only natural niche for M. tuberculosis for tens of thousands of years (Comas
et al., 2013), and therefore Mtb is highly adapted to its host environment. A better understanding
of how Mtb engages in its intracellular lifestyle, and of specific host responses to infection will be
vital to inform both host-directed therapies (Stanley et al., 2014; Zumla et al., 2015) and vaccine
design.
A variety of proteomic approaches have been applied both to mycobacteria (Jungblut et al.,
1999; de Souza et al., 2010; de Souza and Wiker, 2011; Schubert et al., 2015), and cells stimulated
by infection (Rao et al., 2009; Wang et al., 2013) or mycobacterial bioactive lipids (Shui et al.,
2009). Given the intracellular niche within the macrophage that both the vaccine strain M. bovis-
BCG (BCG) and Mtb occupy, a key part of understanding how infection interacts with host innate
and adaptive immunity is to define how proteins are modulated on the surface of infected cells.
This interface between the intracellular and extracellular environment is fundamental to cellular
functions such as cell signaling and nutrition, and therefore a rich source for investigating both
host defenses and pathogenic mechanisms.
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Plasma membrane profiling (PMP) is an unbiased proteomic
approach that combines stable isotope labeling by amino
acids in cell culture (SILAC)–based differential analysis with
selective enrichment of plasma membrane (PM) proteins through
selective oxidation and aminooxy-biotinylation of sialylated PM
glycoproteins (Weekes et al., 2010, 2012). We have employed
PM profiling to identify a cell surface marker of latent human
cytomegalovirus infection, enabling novel approaches to therapy
and diagnosis (Weekes et al., 2013). We applied this technique
for the first time to bacteria-infected human cells to investigate
host-pathogen interactions. Through focusing specifically on
PM proteins, we present an example of the study of a specific
organelle during the course of mycobacterial infection (Rao et al.,
2009; Shui et al., 2009; Li et al., 2011; Jamwal et al., 2013; Wang
et al., 2013; Saquib et al., 2015).
We quantified 559 PM proteins in BCG-infected
macrophages. We used forward- and reverse-labeled SILAC
to identify ‘high confidence’ hits, which included proteins
involved in the innate and adaptive immune systems, adhesion,
and cholesterol metabolism. The cholesterol transporter ABCA1
was significantly upregulated in response to mycobacterial
infection and restricts mycobacterial growth – thus upregulation
of ABCA1 appears to be a novel host restriction factor for
mycobacterial infection.
MATERIALS AND METHODS
Cells and Cell Culture
Human monocytic cells (THP-1) were cultured at 37◦C in SILAC
RPMI-1640 medium (Thermo Pierce) supplemented with 10%
dialyzed fetal calf serum (FCS). Media was supplemented with
either light (Arg 0, Lys 0, Fisher Scientific) or heavy (Arg 10,
Lys 8, Fisher Scientific) amino acids at 50 mg/L and L-proline
at 200 mg/L. The incorporation of heavy label was checked by
analysis of a lysate of 3 × 106 heavy labeled cells generated using
4% Sodium dodecyl sulfate (SDS)/Dithiothreitol (DTT)/Tris
buffer and Filter Aided Sample Processing (FASP) (Wisniewski
et al., 2009). Incorporation was >97% for both arginine
and lysine-containing peptides. Bacille-Calmette–Guerin Pasteur
1173P2 strain (BCG) was grown in 7H9 medium (Difco)
supplemented with oleic acid, albumin, dextrose, and catalase
(OADC), glycerol and 0.025% Tween-20. BCG was grown to
early log phase (OD600 ∼0.4) prior to infection of macrophages.
BCG expressing green fluorescent protein (BCG-GFP) was
constructed by transforming BCG with the episomal plasmid
pMV261-GFP (Stover et al., 1991) and selecting for kanamycin
resistance. All experiments with BCG and M. abscessus (local
clinical isolate, kind gift from Dr. Hairong Huang, Beijing
Tuberculosis and Thoracic Tumor Institute) were carried out
in Biosafety level-2 containment facilities according to local
guidelines and all experiments with M. tuberculosis (strain
H37Rv) in a BSL-3 facility according to local guidelines.
Infection with BCG
THP-1 cells were activated and differentiated into adherent
macrophages by overnight incubation with phorbol-12-
myristate-13-acetate (PMA) at a concentration of 5 ng/ml prior
to infection. Cells were washed and adherent cells infected
with BCG. BCG cultures in logarithmic growth phase were
centrifuged, resuspended, sonicated, filtered through a 5 µm
filter and diluted in serum free SILAC RPMI to achieve a
multiplicity of infection of 5:1. Cells were incubated with BCG
for 4 h at 37◦C and then washed three times with phosphate
buffered saline (PBS) to remove extracellular bacteria still in
suspension. Adherent control cells underwent the same PMA
activation and media changes with PBS washes, but did not
undergo infection. For experiment A, light-labeled cells were
infected with BCG and heavy-labeled cells were the control. For
experiment B, heavy-labeled cells were infected, and light-labeled
cells were the control as a ‘label-swap’.
Preparation of PM Proteins using
Aminooxy-Biotin
Plasma membrane profiling was performed as described
previously (Weekes et al., 2010, 2012), with minor modifications.
Briefly, after 48 h, uninfected and infected adherent cells were
scraped, resuspended, and mixed 1:1, using 5.6 × 107 of each
cell type. Cells were washed twice with ice-cold PBS. Sialic acid
residues were oxidized with sodium meta-periodate (Thermo)
then biotinylated with aminooxy-biotin (Biotium). The reaction
was quenched, and the biotinylated cells resuspended in 1%
Triton X-100 lysis buffer. Biotinylated glycoproteins were
enriched with high affinity streptavidin agarose beads (Pierce)
and washed extensively. Captured protein was denatured with
DTT, alkylated with iodoacetamide (IAA, Sigma) and digested
overnight on-bead with trypsin (Promega) in 50 mM ammonium
bicarbonate pH at 37◦C. For experiment B, ten percent of
the resultant digest was desalted and concentrated by StageTip
(Rappsilber et al., 2007) for immediate analysis. For experiment
A, 90% of the tryptic peptide sample was fractionated by HpRP-
HPLC (see below). For both experiments, beads were further
washed, and incubated overnight with Peptide-N-glycosidase
(PNGase) at 37◦C in G7 buffer. Glycopeptides were collected,
beads were washed once with G7 buffer, and eluates pooled and
concentrated on a StageTip (Rappsilber et al., 2007). Peptides
were enriched and desalted using StageTips.
High pH Reverse-Phase High Pressure
Liquid Chromatography (HpRP-HPLC)
Fractionation and Mass Spectrometric
Analysis
High pH Reverse-phase High Pressure Liquid Chromatography
(HpRp-HPLC) was performed as described previously (Weekes
et al., 2012), using 90% of the tryptic peptide sample from
experiment A with a Dionex Ultimate 3000 powered by an ICS-
3000 SP pump with an Agilent ZORBAX Extend-C18 column
(4.6 mm × 250 mm, 5 µm particle size). Mobile phases (H20,
0.1% NH4OH or MeCN, 0.1% NH4OH) were adjusted to pH 10.5
with the addition of formic acid and peptides were resolved using
a linear 40 min 0.1%−40% MeCN gradient at pH 10.5. Eluting
peptides were collected in 15 s fractions. Fractions were dried
down using an Eppendorf Concentrator and resuspended in 8µL
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MS solvent (3% MeCN, 0.1% TFA). Fractions 24 to 136 inclusive
were analyzed and in each case 3 µL was injected and subjected
to LC-MS/MS using a NanoAcquity uPLC (Waters, MA, USA)
coupled to an LTQ OrbiTrapXL (Thermo, FL, UA). Peptides
were eluted using a gradient rising from 10 to 25% MeCN by
25 min, 40% MeCN by 28 min and 85% MeCN by 29 min.
MS data was acquired between 300 and 1600 m/z at 60,000
FWHM with lockmass enabled (445.120025 m/z). CID spectra
were acquired in the LTQ with MSMS switching operating in a
top 6 DDA fashion triggered at 500 counts. For both experiments,
the glycopeptide samples were eluted using a gradient rising from
3 to 25% MeCN by 90 min, 40% MeCN by 100 min and 85%
MeCN by 102 min. Spectra were acquired using the same MS
parameters.
Database Searching and Data
Processing
Raw MS files were processed using MaxQuant version 1.3.0.5
(Cox et al., 2009, 2011). Raw files from the glycopeptide
samples were searched in parallel with tryptic samples. An
experimental design was specified such that all raw files from
Experiments A and B were analyzed together, with data output
separated within the same spreadsheet. Data were searched
against concatenated Uniprot human and BCG databases, and
common contaminants (Cox et al., 2011). Fragment ion tolerance
was set to 0.5 Da with a maximum of 2 missed tryptic
cleavage sites. Carbamidomethyl cysteine was defined as a
fixed modification, oxidized methionine, N-terminal acetylation
and deamidation (NQ) were selected as variable modifications.
Reversed decoy databases were used and the false discovery
rate for both peptides and proteins were set at 0.01. Protein
quantitation utilized razor and unique peptides and required
a minimum of 2 ratio counts and normalized protein ratios
reported. Peptide re-quantify was enabled in all analyses apart
from where indicated. Significance B values were calculated and
Gene Ontology Cellular Compartment (GOCC) terms added
using Perseus version 1.2.0.161.
To assess the number of PM proteins identified, we summed
the proteins with GOCC terms PM, cell surface but not PM (CS)
and extracellular but not PM/CS (XC) as previously described
(Weekes et al., 2010, 2012). We previously identified a subset
of proteins annotated by GO as integral to the membrane, but
with no subcellular assignment and a short GOCC (ShG) term
(a 4-part term containing the terms ‘integral to membrane’
‘intrinsic to membrane’, ‘membrane part’, ‘cell part’ or a 5-part
term containing ‘membrane’ in addition to these terms) (Weekes
et al., 2010, 2012). Where a majority of proteins identified from
a given sample are annotated PM/CS/XC, it is likely that a
substantial proportion of the proteins with a short GOCC term
are also integral PM proteins – including these proteins provides
a useful upper estimate of the number of identified PM proteins.
To generate a list of proteins quantified with high confidence, we
extracted all proteins quantified in both Experiments A and B.
All such proteins were similarly modulated in both independent
biological repeats.
1http://maxquant.org
Flow Cytometry
THP-1 monocytes were differentiated into macrophages as
described above, and infected with BCG-GFP at an MOI of 5:1 for
4 h. Non-phagocytosed bacteria were washed away as described
above. Cells were harvested at 48 h post-infection and labeled
with antibodies prior to analysis by flow cytometry. The degree of
up- or down-regulation of a protein was calculated by comparing
the mean fluorescent intensity of infected (FL-1HI macrophages
that had phagocytosed green BCG) macrophages with uninfected
macrophages.
Antibodies
Antibodies used for surface staining for flow cytometry were:
anti-ABCA1 (clone AB.H10), anti-CD14-APC (clone 61D3) and
anti-SLAMF7-PE (clone 162) (from: eBioscience, Inc, CA, USA);
and goat anti-mouse-APC (Invitrogen, NY, USA).
Flow Cytometry Analysis
Cells were washed away from plates and stained in PBS with
5% FBS for 30 min at 4C using the monoclonal antibodies
listed above. Cells which stained by unlabeled antibody were
then washed by PBS for 2 times and stained in PBS with 5%
FBS for 30 min at 4C using Alexa Fluor488, Alexa Fluor405
or APC labeled secondary antibody (from Invitrogen). Data
were acquired on an AccuriTMC6 (BD) or a MACSQuant R© VYB
(Miltenyi Biotec) and analyzed using FlowJo software.
Mycobacterial Infection Protocols
THP-1 cells were activated and differentiated into adherent
macrophages by 16 µM phorbol-12-myristate-13-acetate (PMA)
48 h prior to infection. Bacterial cultures in logarithmic growth
phase were centrifuged, washed, resuspended with RPMI-1640
culture medium with 10% FBS, and filtered through a 5 µm
filter to get single cell bacteria. Macrophages were infected
with BCG (MOI of 5:1) for 7 h or M. abscessus (MOI of
5:1) for 4 h or Mtb (MOI of 10:1) for 4 h at 37◦C with 5%
CO2. Then, cells were washed twice with PBS and cultured
in the presence of Amikacin (200 µg/ml) for 1 h to kill
extracellular mycobacteria. Cells were washed three times using
warm PBS to remove Amikacin and then fresh RPMI-1640
with 10% FBS and antibiotics (penicillin and streptomycin)
were added to cells. Simvastatin – 10uM – (Sigma) was
added to activated THP-1 cells 16 h prior to infection and
washed away prior to infection and fresh simvastatin and/or
mevalonate (100 µM, Sigma) added in fresh medium following
infection.
Colony Forming Unit (CFU)
Determination
Virulent Mtb (H37Rv) or M. abscessus was grown to logarithmic
growth phase in Middlebrook 7H9 broth (BD) with BBL
Middlebrook OADC Enrichment (BD) and 0.05% Tween 80
(Sigma). After 4 h infection, infected macrophages were lysed
at 0 h, 20 h, or 44 h incubation. Mycobacteria enumerated
by plating serial dilutions of cell lysates on Middlebrook 7H10
agar plates. Briefly, infected macrophage were lysed with 1%
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Triton X-100 for 5 min and 10-fold dilutions were performed
using 0.05% Tween 80 in PBS before plating on Middlebrook
7H10 (BD) supplemented with 10% oleic acid-albumin-dextrose-
catalase enrichment (Difco). Colonies were counted after 21 days
(Mtb) or 3 days (M. abscessus) of growth at 37◦C. Survival
rate was calculated as the percentage survival of bacteria (as
enumerated by CFU) at time=X compared with lysis and plating
immediately following infection.
Lentivirus Preparation and Infection
Expression vector construction: the RNA interference sequence
was designed as described (Fukuchi et al., 2004). DNA coding
for an RNAi for human ABCA1 was prepared with the
following oligonucleotides: 5-GATCCCCTGAGTTTAGGTATG
GCGGCTTCAAGAGA-3 and 5-TCGAGAAAAATGAGTTTAG
GTATGGCGGCTCTCTTGAA-3. These oligonucleotides were
annealed and ligated into the pEN_H1 vector. Using the
Gateway R© LR recombination reaction, the RNAi sequence was
shuttled into a large expression vector pDSL_hpUGIP.
To package lentivirus: HEK293T cells were seeded 24 h before
transfection. PDSL_hpUGIP or PDSL_hpUGIP contained RNAi
sequence, pMD2.G and psPAX2 were transfected into HEK293T
cells using Lipofectamine R© LTX with PlusTM (from Invitrogen)
following manufacturer’s instruction. Reagents without plasmid
were added into HEK293T as a negative control. Forty-eight
hours after transfection, the supernatants were collected and
filtrated with 0.45 µm filter.
To infect THP-1 cells: fresh RPIM-1640 with 10% FBS was mix
with the filtrated supernatant at 2 to 1 ratio and add to THP-
1 cells. Twenty-four hours after infection, cells were collected
and resuspended with fresh RPIM-1640 with 10% FBS. The
expression of ABCA1 was detected by flow-cytometry 96 h after
infection.
Statistical Analysis
Statistical significance between groups was determined by
unpaired two-tailed Student’s t-test. ∗p< 0.05, ∗∗p< 0.01.
RESULTS
Infection of Human Monocyte THP1 Cells
with BCG Causes Dramatic Changes in
Expression of Plasma Membrane
Proteins
To identify cell surface proteins modulated by BCG infection,
we used ‘plasma membrane profiling’ to compare infected
with control cells. We fractionated peptides using high pH
reversed phase liquid chromatography to increase the number
of proteins quantified. We quantified 873 proteins, of which
559 had a Gene Ontology annotation ‘plasma membrane’ (PM),
‘cell surface’ (CS), ‘extracellular’ (XC), or ‘short GO’ (ShG, see
methods) (70% of all quantified proteins with a GO annotation;
Experiment A). To ensure all light-labeled skin contaminants
were fully excluded, a ‘label swap’ unfractionated sample was
also analyzed which identified 110 proteins, of which 93%
FIGURE 1 | Gene ontology annotations of proteins identified by two or
more peptides in each experiment. In Experiment A, peptides were
fractionated by HpRp, and in Experiment B (label swap) unfractionated. Short
GO terms include the annotations ‘membrane’, ‘integral to membrane’,
‘intrinsic to membrane’, ‘cell part’, but have no information as to subcellular
localization.
(101 proteins) were annotated PM/CS/XC/ShG (Experiment B,
Figure 1). We considered the overlap between Experiments A
and B ‘high confidence’ data, which is displayed in Figures 2A,B;
Supplementary Table S1. Full data is shown in Supplementary
Table S2.
We selected a subset of PM proteins whose expression
was significantly affected by BCG infection and for which
commercially available antibodies were available for flow
cytometry (Figure 3). We confirmed upregulation of the
most significantly upregulated high confidence proteins CD14
and ATP-binding cassette sub-family A member 1 (ABCA1)
(Figures 2 and 3), in addition to SLAM Family Member 7
(SLAMF7) (Figure 3; Supplementary Table S2).
Canonical Pathway Analysis Suggests
BCG Infection Modulates Immune
Interactions and Lipid Metabolism
In order to identify pathways that were modulated upon
BCG infection, we performed Ingenuity Pathways Analysis2
(Ingenuity R© Systems, Mountain View, CA, USA) on all proteins
up- or down-regulated >2.5-fold. In order to increase the ability
of this analysis to detect regulated pathways, we used the full
set of up- or down-regulated proteins derived from Experiment
A. Multiple functional terms suggest an effect of BCG infection
on host immunity, including ‘lipid metabolism’, ‘Immune Cell
Trafficking’, ‘Inflammatory Response’, ‘Antigen Presentation’
and ‘Cell-mediated Immune Response’. Pathways significantly
modulated by BCG infection include CD40 signaling, and
leukocyte extravasation signaling as well as LXR/RXR activation.
The LXR/RXR pathway is linked to lipid metabolism in
macrophages (A-González and Castrillo, 2011).
Numerous Cholesterol-Associated
Receptors Are Differentially Regulated
upon Macrophage Infection
It has been suggested that although mycobacteria are able
to metabolize a wide variety of carbon sources in vitro,
2www.ingenuity.com
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FIGURE 2 | (A) Column chart illustrating high confidence proteins quantified in two independent biological repeat experiments. Ratios are shown as log2, and are
illustrated from Experiment A. (B) Correspondence between protein ratios from Experiments A and B. Ratios are shown as log2.
the key carbon source in vivo is likely to be cholesterol
(Pandey and Sassetti, 2008; Griffin et al., 2011, 2012; Ouellet
et al., 2011). We noted with interest, therefore, that several
proteins highlighted by Ingenuity analysis of ‘lipid metabolism’
pathways were implicated in cholesterol metabolism and
inflammation and were differentially expressed on the PM
following BCG-infection. Upregulated proteins included Zinc
alpha 2-glycoprotein (Ceperuelo-Mallafre et al., 2012), Low
Density Lipoprotein (LDL) Receptor, CD82 (Delaguillaumie
et al., 2004), CXCR7 (Li et al., 2014), and ATP-binding cassette
subfamily A Member 1 (ABCA1) (Ye et al., 2011). Downregulated
proteins included Plasminogen activator inhibitor 1 RNA-
binding protein (Kudo et al., 2004), Sortilin 1 and the Sortilin-
related receptor (Strong et al., 2014), Endothelial cell-selective
adhesion molecule (Inoue et al., 2010), and Ephrin B1 with its
receptor (Lee and Daar, 2009).
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FIGURE 3 | Flow cytometry histograms of a selection of proteins with altered cell surface expression following BCG infection of THP-1
macrophages. Macrophages were infected with BCG-GFP (MOI: 5:1) for 4 h and then analyzed 48 h following infection by flow cytometry. Infected macrophages
(GFPHI) and uninfected macrophages (GFPLO) were compared by mean fluorescent intensity (MFI).
ABCA1 Upregulation Following
Mycobacterial Infection Restricts
Mycobacterial Growth
The cholesterol transporter ABCA1 pumps cholesterol from
inside the cell to the outside (Jin et al., 2015) and may therefore
alter the cellular content of cholesterol available to mycobacteria.
We wished to investigate the functional role for upregulation
of ABCA1 on mycobacterial infection. We noted a robust
upregulation of ABCA1 following stimulation of activated THP-
1 cells by both live and heat-killed BCG (Figure 4A). This
was suggestive of a host response to mycobacterial infection.
To verify that ABCA1 upregulation was not a generalized
response to particle phagocytosis we fed activated THP-1
macrophages with fluorescently labeled beads. Phagocytosis of
the beads was associated with a small down-regulation of surface
ABCA1 expression (Supplementary Figure S1), suggesting that
ABCA1 upregulation was a specific response to stimulation by
mycobacterial components.
Our proteomic experiments were performed on BCG, a
relatively non-pathogenic relative of pathogenic Mtb. We wished
to extend the implications of our data to pathogenic mycobacteria
such as M. tuberculosis and M. abscessus. Previous reports
had noted upregulation of ABCA1 gene expression in murine
macrophages infected by M. tuberculosis-H37Rv (Stavrum et al.,
2012), but not examined ABCA1 protein expression. We verified
that infection of activated THP-1 cells, a human monocytic cell-
line by pathogenic mycobacteria such as M. tuberculosis-H37Rv
(Figure 4B) and M. abscessus (Figure 4C) also led to increased
plasma-membrane expression of ABCA1.
To determine whether ABCA1 upregulation benefits pathogen
or host, we knocked-down ABCA1 expression by RNA
interference. Lentiviral transduction of activated THP-1 cells with
short-hairpin RNA (shRNA) targeting ABCA1 led to decreased
cell-surface expression of ABCA1 (Figure 4D). This knockdown
led to increased survival of intra-cellular M. tuberculosis
(Figure 4E) and M. abscessus (Figure 4F) and this was not due to
differences in infection rate in macrophages where ABCA1 was
knocked down (Supplementary Figure S2).
To determine whether the phenotype associated with
ABCA1 depletion was due to its effects on cellular cholesterol
depletion, we used the pharmacological agents simvastatin
and mevalonate (Parihar et al., 2013). Mevalonate is a
water-soluble precursor of cholesterol and its synthesis by
HMG-CoA reductase is inhibited by simvastatin. Simvastatin
depletes cellular cholesterol stores, which would be rescued
by the addition of mevalonate, and simvastatin treatment
has recently been shown to potentiate TB treatment (Dutta
et al., 2016). Treating THP-1 cells infected with M. abscessus
with simvastatin following knock-down of ABCA1 or empty
vector led to a substantial decrease in mycobacterial survival
(Figure 5), with no difference in mock-treated or ABCA1 knock-
down cells. This suggested that, with the cellular depletion
of cholesterol by simvastatin, ABCA1 inhibition had no
additive effect. Whereas addition of mevalonate rescued the
simvastatin phenotype and mevalonate alone increased intra-
cellular mycobacterial survival, regardless of ABCA1 knock-
down (Figure 5). Taken together, these data are highly suggestive
that ABCA1 upregulation following mycobacterial infection is a
host response to restrict mycobacterial growth by intra-cellular
cholesterol depletion.
DISCUSSION
Our study provides the first application of PMP to investigate
quantitative changes to PM proteins following bacterial infection,
in this case M. bovis-BCG. PMP has until now been applied to
quantify cell surface proteins modulated by individual host or
viral genes (Weekes et al., 2012, 2013) or viral infection (Weekes
et al., 2014). Previous proteomic studies of mycobacterial host-
pathogen interactions have studied whole-cell and phagosomal
proteomes in response to purified mycobacterial components
(Shui et al., 2009, 2011). Infection of host cells by mycobacteria
have investigated cytosolic and nuclear proteomes (Wang et al.,
2013), phagosomes (Rao et al., 2009; Lee et al., 2010; Li et al.,
2011; Singh et al., 2011), mitochondria (Jamwal et al., 2013),
and endoplasmic-reticulum proteomes (Saquib et al., 2015). This
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FIGURE 4 | Continued
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FIGURE 4 | Continued
ABCA1 is upregulated in response to mycobacterial infection and is a mycobacterial restriction factor. Flow cytometry histograms (left) and graph (right)
showing cell-surface ABCA1 staining of THP-1 macrophages infected by (A) fluorescently labeled live or heat-killed BCG (MOI: 5:1), (B) M. tuberculosis-H37Rv-GFP
(MOI: 10:1), (C) M. abscessus-GFP (MOI: 5:1). (D) Relative cell-surface expression of ABCA1 on THP-1 macrophages following lentiviral-mediated knock-down as
measured by flow cytometry. (E) Relative survival of M. abscessus following infection of THP-1 macrophages after 44 h following mock or ABCA1 knockdown.
(F) Relative survival of M. tuberculosis-H37Rv following infection of THP-1 macrophages after 24 h following mock or ABCA1 knockdown. ∗∗p < 0.01 by Student’s
t-test.
FIGURE 5 | Pharmacological depletion of cholesterol in THP-1
macrophages results in decreased intra-cellular mycobacterial
survival. Activated macrophages were pre-treated with simvastatin or
mevalonate or both and infected with M. abscessus (MOI 5:1). Survival of
intra-cellular bacteria was determined 44 h following infection compared with
immediately following phagocytosis (hence survival rates >100%) – see
Materials and Methods. KD = ABCA1 knock-down by lentiviral transduction,
Mock = empty vector. ∗p < 0.05, ∗∗p < 0.01 by Student’s t-test.
is the first study examining specific changes in PM proteins
following mycobacterial infection.
Our analysis highlighted a number of coordinated changes
in surface expression of host proteins, including cell adhesion
(integrin alpha-1, -3, and -7 and ICAM1), innate immunity
(CD14 and CD40) and cholesterol metabolism (ABCA1, zinc
alpha 2-glycoprotein, LDL-R and CD82). We focused on
upregulation of ABCA1 for further functional investigation due
to the proposed critical role of cholesterol as a host-derived
carbon source following tuberculosis infection.
The first indication that pathogenic M. tuberculosis and its
close relative BCG can utilize cholesterol as a major nutrient
both in vitro and in infection of mice and murine macrophages
came from the groups of Eltis and Sassetti (Van der Geize
et al., 2007; Pandey and Sassetti, 2008). Sassetti and Pandey
showed that mutants of M. tuberculosis lacking a cholesterol
importer, Mce4, were highly attenuated in the chronic persistence
phase of murine infection or in activated macrophages (Pandey
and Sassetti, 2008), although cholesterol utilization did not
appear to be essential in a guinea-pig model of infection (Yang
et al., 2011). Utilization of cholesterol as a carbon source
results in a very specific program of gene expression and is
conditionally essential, compared with growth of M. tuberculosis
with ‘standard’ laboratory media (Griffin et al., 2011, 2012).
Specifically inhibiting cholesterol degradation by mycobacteria
using novel small molecule probes restricted growth in host cells
(VanderVen et al., 2015), verifying the importance of cholesterol
utilization by mycobacteria during infection.
Macrophages have a variety of mechanisms for regulation
of cellular cholesterol and lipid content. The cholesterol
transporters ABCA1 and ABCG1 export cholesterol from within
macrophages to the extra-cellular milieu (Jin et al., 2015). ABCA1
is at least partially positively regulated by the liver × receptor
LXR (Ito et al., 2015) and negatively regulated by the microRNA
miR-33 (Rayner et al., 2010).
Regulation of ABCA1 has been previously shown to have
divergent effects on pathogen survival. HIV specifically down-
regulates surface expression of ABCA1 via Nef (Lin et al., 2015),
and upregulation of ABCA1 by all-trans retinoic acid (ATRA)
or LXRs restricts intra-cellular HIV replication (Jiang et al.,
2012). Similarly, upregulation of ABCA1 inhibits hepatitis C
virus (HCV) replication (Bocchetta et al., 2014). However, when
investigating the intracellular bacterium Listeria monocytogenes,
deletion of ABCA1 in the myeloid lineage was protective in
a murine model of pathogenesis (Zhu et al., 2012). Unlike
our data which supports upregulation of ABCA1 following
mycobacterial infection (Figures 1–4), infection of lung epithelial
cells with another intracellular pathogen, Chlamydia pneumoniae
specifically downregulated ABCA1 (Korhonen et al., 2013)
via upregulation of miR-33 (Zhao et al., 2014) and this
was associated with decreased chlamydial survival within the
host cells (Korhonen et al., 2013). In a murine model of
cerebral malaria, ABCA1 deletion resulted in significantly less
pathology due to both decreased inflammation and microparticle
circulation (Combes et al., 2005).
There are no prior direct studies of ABCA1 and mycobacterial
infection. However, a study examining LXR-deficient mice
observed that these mice were highly susceptible to infection
by M. tuberculosis (Korf et al., 2009). Similarly, macrophages
induced with ATRA, a known ABCA1 agonist, restricted
mycobacterial growth (Wheelwright et al., 2014). However, given
that ABCA1 mediates pleiotropic inflammatory responses (Ito
et al., 2015), it is not clear whether these effects are mediated via
cholesterol restriction or other, inflammatory pathways.
In a study by Mahajan et al. (2012), the relatively
non-pathogenic strain of M. tuberculosis, H37Ra, induced
downregulation of ABCA1 gene expression as measured
by RT-PCR. Although we did not measure total ABCA1
expression in response to mycobacterial infection, we noted a
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robust cell-surface expression of ABCA1 in response to both
non-pathogenic (BCG – Supplementary Tables S1 and S2;
Figure 4A) and pathogenic (M. tuberculosis H37Rv and
M. abscessus, Figures 4B,C) mycobacterial infection. Both their
study and ours support a role for cholesterol-restriction by
modulation of ABCA1 expression resulting in decreased intra-
cellular mycobacterial survival. However, their data suggest
mycobacteria specifically down-regulate ABCA1 gene expression
by an unknown mechanism, whereas our data supports
ABCA1 upregulation as a host-mediated response. Our data
showing upregulation of ABCA1 by macrophages pulsed with
dead BCG (Figure 4A) support ABCA1 upregulation as a
host inflammatory response to pathogen-related molecular
patterns.
Our data do not conclusively demonstrate the mechanism
by which ABCA1 upregulation restricts mycobacterial growth
within macrophages. Although it is intriguing to speculate
it is by export of a nutrient essential for mycobacterial
growth, cholesterol, the fact that knockdown or deletion of
ABCA1 also benefits Listeria (Zhu et al., 2012) – a pathogen
not known to catabolise cholesterol, suggests that this may
be a more generalized inflammatory response mediated by
ABCA1 (Ito et al., 2015). Alternatively, the mycobacterial and
Listeria phenotypes may be mediated by different mechanisms:
mycobacterial restriction via depletion of cholesterol as a carbon
source, and Listeria restriction by depletion of cholesterol in the
phagosome membrane, which would limit the effectiveness of
the cholesterol-dependent cytolysin listeriolysin O (Parihar et al.,
2013). Our data using the pharmacological agents simvastatin
and mevalonate support a role for the effects of ABCA1
upregulation to be mediated by its direct effects on intra-
cellular cholesterol stores. Regardless of the precise molecular
mechanism, identification of a novel host-restriction factor
against intra-cellular mycobacterial survival opens avenues for
new treatment modalities targeting the host.
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right quadrant) of BCG compared with the mock-infected control.
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